L. Finney (London, United Kingdom), J. Sallenave (Paris, France)
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
E. Papakonstantinou (Basel, Switzerland), I. Bonovolias (Thessaloniki, Greece), G. Karakioulakis (Thessaloniki, Greece), M. Tamm (Basel, Switzerland), R. Louis (Liege, Belgium), B. Milenkovic (Belgrade, Republic of Serbia), W. Boersma (Alkmaar, Netherlands), K. Kostikas (Larissa, Greece), F. Blasi (Milan, Italy), J. Aerts (Breda, Netherlands), G. Rohde (Maastricht, Netherlands), A. Lakoma (Badalona, Spain), A. Torres (Barcelona, Spain), T. Welye (Hannover, Germany), D. Stolz (Basel, Switzerland)
|    |
Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study
M. Arjomandi (San Francisco, United States of America), S. Vasudevan (San Francisco, United States of America), H. Wong (San Francisco, United States of America), S. Dalton (San Francisco, United States of America), S. Zeng (San Francisco, United States of America)
| |
Investigation of the very early immune response in viral induced experimental asthma exacerbation
R. Bodenstein-Sgro (Borstel, Germany), S. Webering (Borstel, Germany), M. Wegmann (Borstel, Germany)
| |
Club cell secretory protein: a key mediator in Mycoplasma pneumoniae infection.
J. Ledford (Tucson, United States of America), S. Guerra (Tucson, United States of America), F. Martinez (Tucson, United States of America), M. Kraft (Tucson, United States of America)
| |
Host defence functions of BPIFA1 against Non-typeable Haemophilus influenzae
R. Caikauskaite (Sheffield, United Kingdom), A. Mulay (Sheffield, United Kingdom), D. Hood (Harwell, United Kingdom), S. Brown (Harwell, United Kingdom), J. Stewart (Liverpool, United Kingdom), L. Bingle (Sheffield, United Kingdom), C. Bingle (Sheffield, United Kingdom)
|  |
Murine model for investigating virus-induced exacerbations of COPD-related inflammation – preclinical biomarker validation
M. Wolff (Borstel, Germany), N. El-Merhie (Borstel, Germany), S. Bartel (Borstel, Germany), H. Fehrenbach (Borstel, Germany), S. Reuter (Borstel, Germany), S. Krauss-Etschmann (Borstel, Germany)
| |
Microarray analysis of poly(I:C) and IL-13 co-stimulated human airway epithelium
J. Ehlers (Borstel, Germany), C. Vock (Borstel, Germany), H. Fehrenbach (Borstel, Germany)
| |
Human rhinovirus 16 infection of human macrophages impairs internalisation via disrupting the actin cytoskeleton
J. Jubrail (Paris, France), K. Africano-Gomez (Paris, France), F. Herit (Paris, France), P. Burgel (Paris, France), L. Oberg (Molndal, Sweden), E. Israelsson (Molndal, Sweden), K. Thorn (Molndal, Sweden), G. Mayer (Molndal, Sweden), D. Cunoosamy (Molndal, Sweden), N. Kurian (Molndal, Sweden), F. Niedergang (Paris, France)
| |
Human rhinovirus 16 infection of human macrophages impairs their clearance ability by perturbing phagosome maturation
J. Jubrail (Paris, France), K. Africano-Gomez (Paris, France), F. Herit (Paris, France), P. Burgel (Paris, France), L. Oberg (Molndal, Sweden), E. Israelsson (Molndal, Sweden), K. Thorn (Molndal, Sweden), G. Mayer (Molndal, Sweden), D. Cunoosamy (Molndal, Sweden), N. Kurian (Molndal, Sweden), F. Niedergang (Paris, France)
| |
Effect of Hypertonic Saline Solution on cultures of human respiratory epithelium infected by respiratory syncytial virus
J. Figueroa (Buenos Aires, Argentina), D. Primrose (Buenos Aires, Argentina), A. Vdugour (Buenos Aires, Argentina), V. Ochoa (Buenos Aires, Argentina), J. Bitler (Buenos Aires, Argentina), F. Erra Diaz (Buenos Aires, Argentina)
| |
Impairment of respiratory host defence resulting from cigarette smoke-induced changes in airway epithelial cell differentiation
A. van der Does (Leiden, Netherlands), G. Amatngalim (Leiden, Netherlands), J. Schrumpf (Leiden, Netherlands), F. Dishchekenian (Leiden, Netherlands), T. Mertens (Leiden, Netherlands), D. Ninaber (Leiden, Netherlands), A. Van Der Linden (Leiden, Netherlands), C. Pilette (Brussel, Belgium), C. Taube (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands)
| |
Cigarette smoke extracts decrease basal and lipopolysaccharide-induced expression of macrophage receptor with collagenous structure via degradation of p300
K. LEE (Seoul, Republic of Korea), C. Lee (Seoul, Republic of Korea), C. Yoo (Seoul, Republic of Korea)
| |
The activation of NLRP3 inflammasome pathway in COPD is limited in local airways
J. Fu (Chengdu, China), B. Mao (Chengdu, China), S. Wang (Chengdu, China), W. Xiao (Chengdu, China), G. Li (Chengdu, China), L. Wu (Chengdu, China)
| |
The effect of double-stranded RNA on extracellular matrix deposition in an in vitro model of the airway mucosa
C. Banas (Southampton, United Kingdom), A. Hill (Southampton, United Kingdom), C. Blume (Southampton, United Kingdom), D. Davies (Southampton, United Kingdom), E. Swindle (Southampton, United Kingdom)
| |
The effect of dietary fatty acids on respiratory infection in human lung cells
S. Rutting (Sydney, Australia), J. Horvat (Newcastle, Australia), L. Wood (Newcastle, Australia), P. Hansbro (Newcastle, Australia), B. Oliver (Sydney, Australia)
| |
Pseudomonas aeruginosa LasB subverts innate immunity in alveolar macrophages and epithelial cells
S. Kheir (Paris, France), B. Villeret (Paris, France), N. Serafini (Paris, France), R. Voulhoux (Marseille, France), I. Garcia Verdugo (Paris, France), J. Di Santo (Paris, France), J. Sallenave (Paris, France)
| |
BPI Fold Containing Family A Member 1 (BPIFA1) regulates mucosal microbiota and basal Interferon signaling
C. Britto (New Haven, United States of America), S. Khanal (New Haven, United States of America), B. Wu (New York City, United States of America), Y. Li (New York City, United States of America), L. Segal (New York City, United States of America)
| |
Blocking IL-20 pathway limits the development of bacteria induced exacerbation in mice chronically exposed to cigarette smoke.
B. Koné (Lille, France), F. Madouri (Lille, France), O. Barada (Lille, France), G. Kervoaze (Lille, France), E. Vilain (Lille, France), M. Pichavant (Lille, France), P. Gosset (Lille, France)
| |